Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice

被引:85
|
作者
Persson, L
Borén, J
Robertson, AKL
Wallenius, V
Hansson, GK
Pekna, M
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem, S-40530 Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab Cardiovasc Res, S-40530 Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Res Ctr Endocrinol & Metab, S-40530 Gothenburg, Sweden
[4] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
关键词
atherosclerosis; complement; C3; factor B; hyperlipidemia;
D O I
10.1161/01.ATV.0000127302.24266.40
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - To investigate the effect of complement deficiency on atherogenesis and lipidemia, we used mice deficient in the third complement component (C3-/-) or factor B (FB-/-). Methods and Results - Complement-deficient mice were crossed with mice deficient in both apolipoprotein E and the low-density lipoprotein receptor (Apoe-/- LDLR-/-). The percent lesion area in the aorta at 16 weeks, determined by en face analysis, was 84% higher in C3-/- mice than in controls (11.8% +/- 0.4% versus 6.4% +/- 0.8%, mean +/- SEM, P < 0.00005). The C3-/- mice also had 58% higher serum triglyceride levels (P < 0.05) and a more proatherogenic lipoprotein profile, with significantly more low-density lipoprotein cholesterol and very-low-density lipoprotein triglycerides than control mice. The C3-/- mice weighed 13% less (P < 0.01) and had a lower body fat content (3.5% +/- 1.0% versus 13.1% +/- 3.0%, P < 0.01). There were no differences between FB-/- mice and controls. Conclusions - Complement activation by the classical or lectin pathway exerts atheroprotective effects, possibly through the regulation of lipid metabolism.
引用
收藏
页码:1062 / 1067
页数:6
相关论文
共 50 条
  • [21] Assessment of Carotid Atherosclerosis in Normocholesterolemic Individuals With Proven Mutations in the Low-Density Lipoprotein Receptor or Apolipoprotein B Genes
    Huijgen, Roeland
    Vissers, Maud N.
    Kindt, Iris
    Trip, Mieke D.
    de Groot, Eric
    Kastelein, John J. P.
    Hutten, Barbara A.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2011, 4 (04) : 413 - U210
  • [22] Correlation of vasa vasorum Neovascularization and plaque progression in aortas of apolipoprotein E-/-/low-density lipoprotein -/- double knockout mice
    Langheinrich, AC
    Michniewicz, A
    Sedding, DG
    Walker, G
    Beighley, PE
    Rau, WS
    Bohle, RM
    Ritman, EL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (02) : 347 - 352
  • [23] Macrophage expression of peroxisome proliferator-activated receptor-α reduces atherosclerosis in low-density lipoprotein receptor-deficient mice
    Babaev, Vladimir R.
    Ishiguro, Hiroyuki
    Ding, Lei
    Yancey, Patricia G.
    Dove, Dwayne E.
    Kovacs, William J.
    Semenkovich, Clay F.
    Fazio, Sergio
    Linton, MacRae F.
    CIRCULATION, 2007, 116 (12) : 1404 - 1412
  • [24] Constitutive Androstane Receptor Activation Decreases Plasma Apolipoprotein B-Containing Lipoproteins and Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
    Sberna, Anne-Laure
    Assem, Mahfoud
    Xiao, Rui
    Ayers, Steve
    Gautier, Thomas
    Guiu, Boris
    Deckert, Valerie
    Chevriaux, Angelique
    Grober, Jacques
    Le Guern, Naig
    de Barros, Jean-Paul Pais
    Moore, David D.
    Lagrost, Laurent
    Masson, David
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (10) : 2232 - U211
  • [25] Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice
    Ngo, Anh T. P.
    Jordan, Kelley R.
    Mueller, Paul A.
    Hagen, Matthew W.
    Reitsma, Stephanie E.
    Puy, Cristina
    Revenko, Alexey S.
    Lorentz, Christina U.
    Tucker, Erik I.
    Cheng, Quifang
    Hinds, Monica T.
    Fazio, Sergio
    Monia, Brett P.
    Gailani, David
    Gruber, Andras
    Tavori, Hagai
    McCarty, Owen J. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (04) : 1001 - 1017
  • [26] Low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol
    Santo, SE
    Pires, N
    Gerritsen, G
    Bovenschen, N
    van Dijk, KW
    Princen, H
    Bensadoun, A
    Herz, J
    Van Vlijmen, B
    Havekes, L
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 224 - 224
  • [27] Alcohol Consumption in Combination with an Atherogenic Diet Increased Indices of Atherosclerosis in Apolipoprotein E/Low-Density Lipoprotein Receptor Double-Knockout Mice
    Furuta, Yuzo
    Liu, Jinyao
    Himemiya-Hakucho, Ayako
    Yoshimura, Koichi
    Fujimiya, Tatsuya
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 (02) : 227 - 242
  • [28] Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor
    Owen, David M.
    Huang, Hua
    Ye, Jin
    Gale, Michael, Jr.
    VIROLOGY, 2009, 394 (01) : 99 - 108
  • [29] Moxonidine Increases Uptake of Oxidised Low-Density Lipoprotein in Cultured Vascular Smooth Muscle Cells and Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice
    Wang, Yutang
    Nguyen, Dinh Tam
    Anesi, Jack
    Alramahi, Ahmed
    Witting, Paul K.
    Chai, Zhonglin
    Khan, Abdul Waheed
    Kelly, Jason
    Denton, Kate M.
    Golledge, Jonathan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [30] THROMBIN DEGRADATION OF APOLIPOPROTEIN-E OF HYPERTRIGLYCERIDEMIC VERY LOW-DENSITY LIPOPROTEIN REDUCES B/E RECEPTOR RECOGNITION
    GIANTURCO, SH
    KARLIN, JB
    PRASAD, S
    GOTTO, AM
    BRADLEY, WA
    ARTERIOSCLEROSIS, 1982, 2 (05): : A432 - A432